Antivert and Arimidex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Arimidex (anastrozole). Common drug interactions include nephrogenic systemic fibrosis among females and actinomycosis among males.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Arimidex. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Arimidex?

Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 22,642 Arimidex users. Check the latest studies of Arimidex.



On Jul, 10, 2026

34 people who take Antivert and Arimidex together, and have interactions are studied.

Antivert and Arimidex drug interactions.

What are the common drug interactions of Antivert and Arimidex, by gender? *:

female:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Neuralgia (pain in one or more nerves)
  3. Pruritus (severe itching of the skin)
  4. Rash
  5. Scar
  6. Skin burning sensation
  7. Skin discolouration (change of skin colour)
  8. Skin disorder (skin disease)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Skin fibrosis (fibrous tissue formation on skin)

male:

  1. Actinomycosis (infection that causes sores, or abscesses)
  2. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
  3. Ejection fraction decreased (systolic heart failure)
  4. Hypercholesterolaemia (high levels of cholesterol in the blood)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Inflammation
  7. Injury
  8. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  9. Oesophageal ulcer (ulcer of oesophagus)
  10. Oesophagitis (inflammation of oesophagus)

What are the common drug interactions of Antivert and Arimidex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Erythema (redness of the skin)
  2. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  3. General physical health deterioration (weak health status)
  4. Injury
  5. Joint range of motion decreased (disease of joint movement)
  6. Mobility decreased (ability to move is reduced)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Neuralgia (pain in one or more nerves)
  9. Pain
  10. Pain in extremity

50-59:

  1. Obesity (having too much body fat)
  2. Type 2 diabetes mellitus
  3. Fibromyalgia (a long-term condition which causes pain all over the body)
  4. Knee arthroplasty
  5. Neuralgia (pain in one or more nerves)
  6. Neuropathy peripheral (surface nerve damage)
  7. Surgery
  8. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)

60+:

  1. Pain
  2. Wound
  3. Back pain
  4. Death
  5. Dyspnoea (difficult or laboured respiration)
  6. Ejection fraction decreased (systolic heart failure)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Inflammation
  10. Injury

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 14 people, 41.18%
  2. Haemorrhage (bleeding): 14 people, 41.18%
  3. Breast Cancer Metastatic: 14 people, 41.18%
  4. Aortic Valve Incompetence: 14 people, 41.18%
  5. Pain: 5 people, 14.71%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.76%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 11.76%
  8. Orthostatic Hypertension (a medical condition consisting of a sudden increase in blood pressure when a person stands up): 3 people, 8.82%
  9. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 5.88%
  10. Muscle Aches (muscle pain): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Arimidex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Antivert and Arimidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arimidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arimidex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and anastrozole (the active ingredients of Antivert and Arimidex, respectively), and Antivert and Arimidex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: